New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features
Costantino Ricci(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Michelangelo Fiorentino(Azienda USL di Bologna), Agnese Orsatti(Azienda USL di Bologna), Eugenia Franchini, Francesco Vasuri(Ospedale "Santa Maria delle Croci" di Ravenna), Francesco Massari(Altera (United States)), Nuno Tiago Tavares(Instituto Português de Oncologia Francisco Gentil), Alessia Grillini, João Lobo(Universidade do Porto), Francesca Ambrosi, Andres Martin Acosta(Indiana University School of Medicine), Federico Mineo Bianchi(University of Bologna), Veronica Mollica(Azienda USL di Bologna), Fernanda Fernandes-Pontes(Universidade do Porto), Luisa Di Sciascio(Azienda USL di Bologna)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
January 21, 2026
Cited by 2
Related Papers
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
|Cells|2020|256
Integrative epigenetic taxonomy of primary prostate cancer
|Nature Communications|2018|167
Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
|International Journal of Molecular Sciences|2019|141
Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study
|Osteoporosis International|2017|119